Seoul, South Korea

Key-Sun Kim

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002-2020

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Key-Sun Kim: Innovator in Neuropathic Pain Treatment

Introduction

Key-Sun Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of neuropathic pain and neurodegenerative diseases. With a total of 5 patents, his work has the potential to impact many lives.

Latest Patents

One of his latest patents is titled "Method of restoring analgesic efficacy of alpha2-adrenoceptor agonists in neuropathic pain treatment." This patent provides a pharmaceutical composition that includes an alpha 2 (α2)-adrenoceptor agonist, a regulator of G-protein signaling (RGS) inhibitor, an endocytosis inhibitor, or a combination thereof, along with a pharmaceutically acceptable salt. The method aims to relieve pain in subjects by administering this composition. Another notable patent is for "Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative brain disease containing the same." This patent introduces novel benzoarylureido compounds that can be used for the prevention and treatment of various neurodegenerative brain diseases, including Alzheimer's disease, dementia, and Parkinson's disease.

Career Highlights

Key-Sun Kim is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development. His work is characterized by a strong focus on innovative solutions for complex medical challenges.

Collaborations

Some of his notable coworkers include Eunice Eun-Kyeong Kim and Kyung Il Choi, who contribute to the collaborative efforts in advancing research in their field.

Conclusion

Key-Sun Kim's innovative work in the pharmaceutical industry highlights his commitment to improving treatment options for neuropathic pain and neurodegenerative diseases. His patents reflect a dedication to scientific advancement and the potential to enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…